MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by Sugammadex by Nithya A. Fernandopulle et al
- PMID: 33527585
- DOI: 10.1111/cea.13837
MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by Sugammadex by Nithya A. Fernandopulle et al
Comment in
-
Reply to correspondence of Elst et al.Clin Exp Allergy. 2021 Jul;51(7):978-979. doi: 10.1111/cea.13844. Epub 2021 Mar 8. Clin Exp Allergy. 2021. PMID: 33548115 No abstract available.
Comment on
-
MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.Clin Exp Allergy. 2021 May;51(5):685-695. doi: 10.1111/cea.13801. Epub 2020 Dec 20. Clin Exp Allergy. 2021. PMID: 33275825
References
REFERENCES
-
- Fernandopulle NA, Zhang S, Soeding PF, Mackay GA. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: modulation by sugammadex. Clin Exp Allergy. 2020.
-
- McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015;519:237-241.
-
- Porebski G, Kwiecien K, Pawica M, Kwitniewski M. Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol. 2018;9:3027.
-
- Ebo DG, Van der Poorten ML, Elst J, et al. Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity. Br J Anaesth. 2020;126:e27-e29.
-
- Lansu K, Karpiak J, Liu J, et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat Chem Biol. 2017;13:529-536.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
